Closed loop insulin delivery and glucose control for type 1 diabetes, seven days and nights, hospital to home.

Phase 2

Completed

• Conditions: type 1 diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12614000482662
• Lead Sponsor: Martin de Bock

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-05-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

Age 12-50 years with type 1 diabetes
Duration of diabetes at least 12 months
On insulin pump therapy for at least 6 months
Carbohydrate counting
Using bolus calculator function
HbA1C<9%

Exclusion Criteria

Pregnancy
Any alcoholic or substance abuse
Undergoing treatment for psychological illness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
time spent with sensor blood glucose between 3.9 – 10mmol/L[Calculated after 7 days];hypoglycaemic events (sensor blood glucose <3.3mmol/L) [Count at the end of 7 days]

Secondary Outcome Measures

Name	Time	Method
nil[nil]